PharmEasy Share Price Overview
What Is PharmEasy?
Pharmeasy is the India’s leading and fastest growing digital healthcare platform. It is offering all services like information, consultations, health tests, medicines, healthcare equipment and services from registered and trusted pharmacies, leading diagnostic laboratories and trusted doctors across all India, serving every possible and demanding zip codes of the country.
The journey of Pharmeasy was started in 2014, when founder Dharmil Sheth, an MBA pass from IMT Ghaziabad and Co-founder Dr Dhaval Shah, MBBS from Rajiv Gandhi Medical College and MBA from XLRI Jamshedpur, They came up with the idea of an online pharmacy platform to make healthcare affordable and easy to one and all.( Read More Here for Pharmeasy Share Price)
Overview OF Pharmeasy
Pharmeasy is the India’s biggest and valuable digital healthcare platform (based on GMV of products and services sold for the year ended March 31, 2021), according to RedSeer Report. (Pharmeasy Peers)
They started an new and end-to-end business that aims to provide complete solutions for healthcare needs of consumers across the following critical stages
A. providing digital applications and information on diseases and wellness.
B. offering Teleconsultation.
C. offering diagnostics and Radiology tests.
D. delivering treatment tips and solutions including products and devices.
Pharmeasy custom- erected personal technology, unified data platforms, force chain capabilities, and deep understanding of the dynamic interplay between the colorfulsub-segments of India’s healthcare request are the capabilities that separate us.
These abilities makes Pharmeasy to provide each stakeholder in the healthcare value-chain, viz.:
(a) channels (wholesalers, retailers and chemists / institutions).
(b) consultants (and hospitals), diagnostic centers and radiology labs.
(c) consumers
(d) companies (pharmaceutical, nutraceutical, medical devices).
Pharmeasy IPO Details
API Holdings Limited has filed its DRHP on 8th November 2021 and will be coming out with their IPO in this financial year.
Pharmeasy
Fresh Issue
₹ 6250.00 Cr
Pharmeasy
Total IPO Size
₹6250 Cr
Pharmeasy Funding
Funded By | Funding Amount | Date of Investment | Funding Round | Fund Name |
---|---|---|---|---|
InnoVen Capital | ₹ 450 M | 11 Sep 2018 | - | Debt Financing |
Temasek Holdings | $ 220 M | 27 Nov 2019 | Series D | - |
B Capital Group | $ 20 M | 17 Jun 2021 | Secondary | - |
IIFL Finance | $ 146 M | 18 Oct 2021 | Secondary | - |
Trifecta Capital Advisors | - | 20 Oct 2021 | - | Debt Financing |
Eight Roads Ventures India | $ 50 M | 26 Sep 2018 | Series C | - |
Prosus Ventures, TPG Growth | $ 390 M | 07 Apr 2021 | Series E | - |
Steadview Capital | $ 204 M | 18 Oct 2021 | - | Venture Round |
VestinWolf Capital Management | - | 01 Nov 2021 | - | Private Equity Round |
Arokiaswamy Velumani | $ 500 M | 07 Jul 2021 |
Visit For More:- Pharmeasy Board Of Directors
Comments
Post a Comment